The Medicube PDRN Pink Peptide Serum is a Korean skincare treatment designed to rejuvenate, hydrate, and firm the skin. Its formulation combines advanced peptides, DNA repair agents, and hydrating ingredients to address signs of aging, uneven texture, and skin sensitivity.wardobie.com
🌸 Key Ingredients & Benefits
-
Salmon DNA PDRN (10,000 ppm): Polydeoxyribonucleotide (PDRN) derived from salmon DNA stimulates skin renewal and repair, promoting a clearer, more luminous complexion and an even skin tone. picknpamper.com+3wardobie.com+3nypost.com+3
-
Peptide Complex: Includes five types of peptides, such as Palmitoyl Tripeptide-1 and Acetyl Hexapeptide-8, which enhance skin elasticity, reduce fine lines, and support collagen production. theskincarelibrary.com+2wardobie.com+2kbeautyarabia.com+2
-
Niacinamide: Brightens the skin, reduces hyperpigmentation, and improves skin barrier function.
-
Hyaluronic Acid: Provides deep hydration, plumping the skin and improving elasticity.wardobie.com
-
Ocimum Sanctum (Holy Basil) Leaf Extract: Calms irritation and strengthens the skin’s barrier.picknpamper.com
-
Coenzyme Q10: Offers antioxidant protection and supports skin vitality.
💧 Texture & Usage
The serum features a lightweight, non-sticky pink formula that absorbs quickly into the skin. It is suitable for daily use, both morning and night. To apply, dispense a few drops onto cleansed skin and gently pat until fully absorbed. Follow with a moisturizer to lock in hydration.kbeautyarabia.com
🧪 Dermatological Testing
The serum is hypoallergenic and has undergone dermatological testing, making it safe for sensitive skin types. It is free from artificial colors and gluten. kbeautybliss.comtheskincarelibrary.com

Medicube TXA Capsule Cream
Medicube Zero Pore One Day Serum
Medicube Vitamin C Cream
medicube ZERO PORE BLACKHEAD MUD MASK
medicube PDRN PINK COLLAGEN CAPSULE CREAM
medicube RED SUCCINIC ACID SERUM
medicube ONE DAY EXOSOME SHOT 7500
medicube pdrn pink peptide serum
medicube serum 15% 








Reviews
There are no reviews yet.